
Recombinant human growth hormone injection does not improve healing rate versus control in RC repair

Recombinant human growth hormone injection does not improve healing rate versus control in RC repair
Effect of recombinant human growth hormone on rotator cuff healing after arthroscopic repair: preliminary result of a multicenter, prospective, randomized, open-label blinded end point clinical exploratory trial
J Shoulder Elbow Surg. 2018 May;27(5):777-785Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
91 patients scheduled for arthroscopic rotator cuff repair were randomized to either postoperative injections of weekly 4mg or 8mg recombinant human growth hormone (rhGH), or to a control with no postoperative injections. Patients were assessed for healing rate using the Sugaya classification, fatty infiltration and atrophy on MRI, and for clinical scores and range of motion over the first 6 month...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.